Economic impact of the Florida cultured hard clam industry

(29pp.

A computer program for statistically-based decision analysis

The majority of patients with coronary artery disease do not fall into the well defined populations from randomized clinical trials. Observational databases contain a rich source of information that could be used by practicing physicians to evaluate treatment alternatives for their patients. We describe a computer system, the CABG Kibitzer, which uses an integrated approach to evaluate the treatment alternatives for CAD patients. We combine a statistical multivariate model for calculating survival advantages with DA techniques for assessing patient preferences and sensitivity analysis, to create one tool that physicians find easy to use in daily clinical practice. The development of tools of this kind is a necessary step in making the data of outcome studies accessible to practicing physicians

Resistant calcification responses of Arctica islandica clams under ocean acidification conditions

Ocean acidification (OA) directly impacts marine calcifying organisms including ecologically and commercially important shellfish species such as Arctica islandica (A. islandica). To test whether documented growth resilience of A. islandica to OA is a general response across ages and populations or a function of adaptation to local habitat, we cultured juvenile and adult clams collected from an environment with little pH variation under four pH levels (7.5, 7.7, 7.9, and 8.1) for three months and integrated our understanding with relevant literature. The average shell growth over the experiment among all (69) individuals was 57 ± 55 μm, and there were no statistically significant differences in growth among pH treatments, including the control treatment, despite the general growth rate differences between juveniles and adults. Our results show that A. islandica can maintain its shell growth even in aragonite undersaturated (Ω < 1) conditions (0.65 and 0.83 for pH 7.5 and 7.7 treatments, respectively), supporting the hypothesis that resistance to OA conditions is likely a generalized response across populations. Although the present results show A. islandica can maintain their shell growth under short-term OA, long-term impacts of OA on A. islandica shell growth and other physical parameters including shell density and microstructure are still needed to better assess the sustainability of A. islandica in a more acidified future and to provide guidance on managing this important shellfish stock.publishedVersio

Association between class III obesity (BMI of 40-59 kg/m2) and mortality: A pooled analysis of 20 prospective studies

Background The prevalence of class III obesity (body mass index [BMI]≥40 kg/m2) has increased dramatically in several countries and currently affects 6% of adults in the US, with uncertain impact on the risks of illness and death. Using data from a large pooled study, we evaluated the risk of death, overall and due to a wide range of causes, and years of life expectancy lost associated with class III obesity. Methods and Findings In a pooled analysis of 20 prospective studies from the United States, Sweden, and Australia, we estimated sex- and age-adjusted total and cause-specific mortality rates (deaths per 100,000 persons per year) and multivariable-adjusted hazard ratios for adults, aged 19–83 y at baseline, classified as obese class III (BMI 40.0–59.9 kg/m2) compared with those classified as normal weight (BMI 18.5–24.9 kg/m2). Participants reporting ever smoking cigarettes or a history of chronic disease (heart disease, cancer, stroke, or emphysema) on baseline questionnaires were excluded. Among 9,564 class III obesity participants, mortality rates were 856.0 in men and 663.0 in women during the study period (1976–2009). Among 304,011 normal-weight participants, rates were 346.7 and 280.5 in men and women, respectively. Deaths from heart disease contributed largely to the excess rates in the class III obesity group (rate differences = 238.9 and 132.8 in men and women, respectively), followed by deaths from cancer (rate differences = 36.7 and 62.3 in men and women, respectively) and diabetes (rate differences = 51.2 and 29.2 in men and women, respectively). Within the class III obesity range, multivariable-adjusted hazard ratios for total deaths and deaths due to heart disease, cancer, diabetes, nephritis/nephrotic syndrome/nephrosis, chronic lower respiratory disease, and influenza/pneumonia increased with increasing BMI. Compared with normal-weight BMI, a BMI of 40–44.9, 45–49.9, 50–54.9, and 55–59.9 kg/m2 was associated with an estimated 6.5 (95% CI: 5.7–7.3), 8.9 (95% CI: 7.4–10.4), 9.8 (95% CI: 7.4–12.2), and 13.7 (95% CI: 10.5–16.9) y of life lost. A limitation was that BMI was mainly ascertained by self-report. Conclusions Class III obesity is associated with substantially elevated rates of total mortality, with most of the excess deaths due to heart disease, cancer, and diabetes, and major reductions in life expectancy compared with normal weight